ATPase H+ transporting V0 subunit c pseudogene 3 (ATP6V0CP3)

ATP6V0CP3 (ATPase H+ transporting V0 subunit c pseudogene 3) is classified as a *pseudogene*, meaning it is a genomic DNA sequence similar to a known gene but is non-functional; it does not code for a protein[1][2]. Pseudogenes are conventionally considered non-coding elements, though some can have regulatory roles in gene expression at the RNA level, such as acting as microRNA decoys or generating non-coding RNAs that regulate their protein-coding relatives[3][4]. ATP6V0CP3 is not considered a therapeutic target because it lacks protein-coding ability and direct physiological function; there are no drugs or biomarkers linked to it. There is nothing to suggest a direct disease relationship specific to ATP6V0CP3, although the general family of pseudogenes may, in some instances, be relevant to gene regulatory networks in cancer and other diseases[3][4]. There are no standard aliases, no known interaction with drugs or classified mechanisms of action, and it should **not** be considered an actionable pharmacological or clinical target.

None (see above)